Latest headlines
AbbVie News
The latest AbbVie (ABBV) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these ABBV headlines next to the live AbbVie Fear and Greed Index.
Latest AbbVie Headlines33
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
zacks.com · Aug 27, 2026
AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
prnewswire.com · Aug 27, 2026
Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus
fool.com · Aug 26, 2026
How Did ABBV's Oncology Sales Hold Up in Q2 Amid Imbruvica Headwinds?
zacks.com · Aug 25, 2026
LLY vs. ABBV: Which Stock Has the Stronger Growth Prospects?
zacks.com · Aug 25, 2026
AbbVie Still Has Room To Run
seekingalpha.com · Aug 24, 2026
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.
fool.com · Aug 24, 2026
AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline
prnewswire.com · Aug 21, 2026
PPH vs. IYH: Which Healthcare Fund Is the Better Buy?
fool.com · Aug 18, 2026
AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support
prnewswire.com · Aug 18, 2026
Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year
fool.com · Aug 16, 2026
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Aug 14, 2026
Can ABBV's Neuroscience Drugs Drive Growth in the Second Half of 2026?
zacks.com · Aug 14, 2026
Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins?
fool.com · Aug 14, 2026
Simplify's PINK or iShares' IYH: Which Healthcare ETF Should Long-Term Investors Choose Right Now?
fool.com · Aug 13, 2026
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Aug 11, 2026
How Much Did Immunology Drugs Contribute to AbbVie's Q2 Performance?
zacks.com · Aug 11, 2026
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?
fool.com · Aug 11, 2026
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry?
fool.com · Aug 11, 2026
Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?
fool.com · Aug 10, 2026
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Aug 7, 2026
ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?
zacks.com · Aug 6, 2026
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now
fool.com · Aug 5, 2026
Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?
zacks.com · Aug 5, 2026
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
prnewswire.com · Aug 4, 2026
ABBV Q2 Earnings Call Balances Growth With Apogee Dilution
zacks.com · Aug 3, 2026
AbbVie: Strong Q2 And New Catalysts Keep Me Bullish
seekingalpha.com · Aug 3, 2026
Why AbbVie Stock Slumped Today
fool.com · Jul 31, 2026
AbbVie Inc. (ABBV) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 31, 2026
AbbVie Inc (ABBV) (Q2 2026) Earnings Call Highlights: Robust Growth Driven by Skyrizi and Rinvoq, Pipeline Advances
gurufocus.com · Jul 31, 2026
ABBV Beats on Q2 Earnings & Sales, Cuts '26 EPS View, Stock Down
zacks.com · Jul 31, 2026
Pre-Market Trading Up in Final Session of the Week
zacks.com · Jul 31, 2026
AbbVie Q2 Earnings Call Highlights
marketbeat.com · Jul 31, 2026
Why Is AbbVie Up or Down Today?
When AbbVie (ABBV) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a ABBV move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why AbbVie is up or down today.
How AbbVie News Affects the Price
News does not move the AbbVie (ABBV) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the AbbVie Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in AbbVie trading volume. That is the chain to watch: headline, sentiment, volume, then the ABBV price.
Trade the AbbVie News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch AbbVie trading volume spike on a big story, check the AbbVie price history for context, follow the live ABBV price, see the AbbVie price prediction, and read the AbbVie Fear and Greed Index for mood.
How do you feel about AbbVie?
1DFrequently asked questions
Why is AbbVie up or down today?
What is the latest AbbVie news?
Where does AbbVie news come from?
How often is AbbVie news updated?
How does AbbVie news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.